Drawing for ONEMAP

USPTO serial 79442497

ONEMAP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with ONEMAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pamela N. Hirschman

Pamela N. Hirschman Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software and downloadable software application for biological, chemical and medical analysis; downloadable software and downloadable software applications for medical diagnosis; electronic databases in the fields of biology, chemistry and medicineACTIVE—
035Database management; collection of data, namely, medical, chemistry and biological data, for business purposes; data systematization in computer databases; provision of data, namely, compilation of medical, chemistry and biological information into computer databases; compilation of information in computer databases in the field of biology, chemistry, medicine; services for gathering data in computer databases, namely, compilation of information in computer databases in the field of biology, chemistry, medicine; systematization of information in computer databases; data processing services; updating of data and metadata in computer databases; subscriptions to database services, namely, arranging of subscriptions to databases for others by telecommunications; all the aforesaid services in the fields of biological and chemical analyses, medical diagnostics and clinical trialsACTIVE—
042Design, development, installation, updating, maintenance of computer software; Software as a Service (SaaS) services featuring software for biological, chemical and medical analysis; design and development of databases, conducting of scientific and technical studies in the fields of biology, chemistry, medicine; scientific and technological services, namely, analysis, research and design services in the field of medical diagnostics; development and testing of methods and algorithms in the field of medical diagnostics; electronic data storage; hosting of databases; all the aforesaid services being in the fields of biological and chemical analyses, medical diagnostics and clinical trialsACTIVE—
044Single-cell medical testing and analysis services for cancer prognosis, diagnosis and treatment as well as for diagnosis or treatment of other diseases; medical services; diagnostic services, namely, medical diagnostic testing for cancer as well as for other diseases and disorders; medical testing services for diagnostic or treatment purposes; medical testing for the diagnosis and treatment of persons; medical laboratory analysis services relating to the treatment of persons; medical services in the field of oncology and other medical fields; provision of medical information in the field of health; providing screening services for cancer and other diseases, namely, providing medical diagnostic testing services consisting essentially of chemical analysis and use of bioinformatics tools for cancer screening; provision of medical information collected and analyzed for the purpose of diagnosis or treatment of cancer and other diseases and disorders; provision of medical data and information intended for healthcare professionalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 2, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 31, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2026DOCKASSIGNED TO EXAMINER—
Jan 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 29, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance